Skip to content

"Shock Wave in Trigger finger"

Efficacy assessment of Extracorporal ShockWave Therapy (ESWT) in treatment of Trigger finger patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170915036191N2
Enrollment
19
Registered
2018-02-08
Start date
2018-02-09
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger finger. Trigger finger, unspecified finger

Interventions

Target group consists of 19 Trigger finger patients. Every patient will be treated by Extra Corporal Shock Wave Therapy for 3 weeks (1 week interval between sessions). Radial head protocol includes 10

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Trigger finger, grade 1 or more

Exclusion criteria

Exclusion criteria: Previous treatment in less than last 6 months, including corticosteroid injection or surgical release Bleeding disorders Pregnancy Malignancy Local infection Arrhythmia and cardiac pace maker

Design outcomes

Primary

MeasureTime frame
Pain intensity due to Visual Analogue Scale (0-10). Timepoint: Pain intensity due to Visual Analogue Scale system, before, immediately after, 6 weeks and 18 weeks after treatment. Method of measurement: Visual Analogue Scale (0-10).;Trigger finger grading: due to Quinnell Trigger finger score. Timepoint: Before, immediately after, 6 weeks and 18 weeks after treatment. Method of measurement: Quinnell Trigger finger score.;Dysfunction: due to Quick Disability of Arm, Shoulder and Hand System. Timepoint: Before, immediately after, 6 weeks and 18 weeks after treatment. Method of measurement: Quick Disability of Arm, Shoulder and Hand System.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahime Momeni

Esfahan University of Medical Sciences

f.momeni@resident.mui.ac.ir+98 31 3670 0666

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026